CorMedix Inc. — Quarterly Financial Statements (NASDAQ:CRMD) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Market Capitalization 541.3826 M
Employee 82
Founded 2006
CEO N/A
Website www.cormedix.com
Headquarter Delaware, United States
FIGI BBG000Q4BQK0
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

541.38 M Market capitalization

Price to earnings ratio

5.56

Price to sales ratio

4.07

Dividends per share

—

Dividend yield %

—

Nachrichten

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?

Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?

CorMedix Inc. (CRMD) Analyst/Investor Day Transcript

CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11

CorMedix: Citizens bekräftigt hohes Kursziel und sieht Milliardenpotenzial bei REZZAYO

CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside

CorMedix stock rises after announcing $75 million share buyback plan

CorMedix startet Aktienrückkaufprogramm über 75 Millionen US-Dollar

CorMedix announces $75 million share repurchase program

CRMD Down 31% in a Month: Is This an Indication to Sell the Stock?